Buchumschlag

Dabrafenib as a Therapeutic Option for Chemotherapy‐Refractory Pediatric Juvenile Xanthogranuloma

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Mengxuan Wang, Jian Ge, Honghao Ma, Tianyou Wang, Zhigang Li, Rui Zhang
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2025
Schlagworte:	Pediatric Blood & Cancer
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Trametinib Monotherapy in the Treatment of Pediatric Refractory/Relapse Langerhans Cell Histiocytosis
von: Wenqian Wang, et al.
Veröffentlicht: (2026)

Severe Congenital Systemic Juvenile Xanthogranuloma With Neonatal Acute Liver Failure, Neonatal Hemochromatosis and Placental Infiltration
von: Wing‐Yan Leung, et al.
Veröffentlicht: (2026)

Venetoclax Combined With Chemotherapy in Pediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
von: Andrew E. Place, et al.
Veröffentlicht: (2025)

Gemcitabine, Docetaxel, Melphalan, Carboplatin as Part of Sequential Cycles of High‐Dose Chemotherapy With Autologous Hematopoietic Stem‐Cell Rescue for Multiply Relapsed/Refractory Pediatric Germ Cell Tumors
von: Maria Frost, et al.
Veröffentlicht: (2026)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Pediatric Abdominal Rhabdomyosarcoma: Experience of a Reference Pediatric Oncosurgical Center
von: Cristian Urla, et al.
Veröffentlicht: (2025)

Safety and Efficacy of Romiplostim in Maintaining Chemotherapy Interval and Dose Intensity in Pediatric Patients With Solid Tumors and Chemotherapy‐Induced Thrombocytopenia
von: Erica Tonti, et al.
Veröffentlicht: (2026)

Venetoclax Alone or in Combination With Chemotherapy in Paediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Myeloid Leukaemia
von: Seth E. Karol, et al.
Veröffentlicht: (2025)

Dexamethasone for Chemotherapy‐Induced Nausea and Vomiting Prevention in Pediatric Patients: International Consensus
von: Negar Shavandi, et al.
Veröffentlicht: (2026)

Successful Management of Refractory Congenital Hemangioma With Sirolimus in a Neonate
von: Yanyu Hou, et al.
Veröffentlicht: (2025)

Clinical Features and Therapeutic Evaluation of Central Nervous System Involvement in Pediatric Anaplastic Large Cell Lymphoma
von: Xiaomei Yang, et al.
Veröffentlicht: (2025)

Overcoming Chemotherapy Resistance in EBF1–PDGFRB‐Positive B‐ALL: A Novel Therapeutic Approach Using Dasatinib and Blinatumomab
von: Jinyu Fu, et al.
Veröffentlicht: (2025)

Venetoclax in Pediatric and Young Adult Patients With Relapsed/Refractory Solid Tumors: Results of a Phase 1 Study
von: Daniel A. Morgenstern, et al.
Veröffentlicht: (2026)

Intestinal Low‐Dose Radiation to Overcome PD‐1 Resistance in Pediatric Relapsed/Refractory Hodgkin Lymphoma
von: Shubham Sahni, et al.
Veröffentlicht: (2026)

A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric and Young Adult Solid Tumors
von: Filemon S. Dela Cruz, et al.
Veröffentlicht: (2025)

Pediatric Recurrent Spinal Arteriovenous Malformations: Genetic Testing and Novel Therapeutic Approaches
von: Valentina Roa Forster, et al.
Veröffentlicht: (2025)

Infectious Morbidity During Pediatric Acute Myeloid Leukemia Chemotherapy in a High‐Income Country: A 15‐Year Population‐Based Overview
von: Emily R. Schwartz, et al.
Veröffentlicht: (2025)

Optimizing Options for Future Third‐Party Reproduction Among Youth Newly Diagnosed With Cancer: Considerations for Pediatric Fertility Preservation Counseling
von: James L. Klosky, et al.
Veröffentlicht: (2026)

Cervical Lymph Node Invasion in Pediatric Salivary Gland Malignancies: Clinical Overview and Therapeutic Implications
von: Celine Richard, et al.
Veröffentlicht: (2025)

Results of the Latin American Pediatric Oncology Group (GALOP) Trial for Patients With Metastatic Ewing Sarcoma: Multicentric Study of Interval‐Compressed Multiagent and Metronomic Chemotherapy
von: Adriana Rose, et al.
Veröffentlicht: (2025)

Personalized Selumetinib Dosing in Pediatric Neurofibromatosis Type 1: Insights From a Pilot Therapeutic Drug Monitoring Study
von: Janka Kovács, et al.
Veröffentlicht: (2026)

Clinical and Genetic Characteristics of Pediatric Colorectal Cancer
von: Qiyang Shen, et al.
Veröffentlicht: (2025)

A Novel TAL2::TCRB Fusion With PI3K/AKT Pathway Mutations in Pediatric T‐Cell Acute Lymphoblastic Leukemia: Diagnostic and Therapeutic Implications
von: Qiang Yao, et al.
Veröffentlicht: (2025)

Results of the Latin American Pediatric Oncology Group (GALOP‐2011) Trial for Patients With Localized Ewing Sarcoma: A Multicentric Study of Interval‐Compressed Multiagent Chemotherapy
von: Lauro José Gregianin, et al.
Veröffentlicht: (2025)

Pediatric Mixed Phenotype Acute Leukemia With ETV6 :: ARNT Fusion Gene Successfully Treated by Allogeneic Hematopoietic Stem Cell Transplantation
von: Yaoyao Rui, et al.
Veröffentlicht: (2025)

Reduced‐Intensity Chemotherapy With Immunotherapy for Children With Down Syndrome and B‐Cell Acute Lymphoblastic Leukemia
von: Ashley C. Holland, et al.
Veröffentlicht: (2025)

Current Status and Challenges in Pediatric Radiation Therapy in China: A Nationwide Survey
von: JunFang Liao, et al.
Veröffentlicht: (2025)

Vincristine Sulfate Liposome Injection With Combination Chemotherapy for Children, Adolescents, and Young Adults With Relapsed Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia and Lymphoma Consortium Trial
von: Nirali N. Shah, et al.
Veröffentlicht: (2025)

What Is the Expected Clearance of Methotrexate? A Therapeutic Drug Monitoring Reference Guide for High‐Dose Methotrexate Use in Pediatric Malignancies
von: Zachary L. Taylor, et al.
Veröffentlicht: (2025)

Refractory juvenile xanthogranuloma of the mastoid bone responsive to trametinib
von: Isaac Hauk, et al.
Veröffentlicht: (2024)

Urgent Chemotherapy for Swift Symptom Relief in Patients With Medulloblastoma
von: Aseel Bzour, et al.
Veröffentlicht: (2025)

Outcome of Premature Infants Treated With Chemotherapy for Neuroblastoma in France
von: Dana Al Khalifa, et al.
Veröffentlicht: (2025)

Azacytidine Monotherapy in an Infant With Mosaic NRAS ‐Driven Juvenile Myelomonocytic Leukemia
von: Jeremy M. Grenier, et al.
Veröffentlicht: (2025)

Response to trametinib Monotherapy Without Hematopoietic Stem Cell Transplant in Juvenile Myelomonocytic Leukemia
von: Rozalyn Chok, et al.
Veröffentlicht: (2026)

Homoharringtonine in Relapsed/Refractory Paediatric T‐Cell Acute Lymphoblastic Leukaemia—A Case Series and a Report on the Use of In Vitro Drug Profiling
von: Pui Yung Grace Tong, et al.
Veröffentlicht: (2025)

Caregiver Well‐Being and Pediatric Healthcare Utilization in Youth With Sickle Cell Disease: The Role of Caregiver and Child Factors
von: Theresa L. Kapke, et al.
Veröffentlicht: (2025)

Pediatric RISE: Development of a Poverty‐Targeted Cash Support Intervention for Pediatric Cancer
von: Colleen A. Kelly, et al.
Veröffentlicht: (2025)

Sustained Remission of Refractory EBV‐Associated CNS Post‐Transplant Lymphoproliferative Disorder After Cord Blood Transplantation Using Donor‐Derived CD19/CD20 Bispecific CAR‐T Cells in a Pediatric Patient With GATA2 Deficiency
von: Yuanyuan Ren, et al.
Veröffentlicht: (2025)

COVID‐19 Vaccine Response in Pediatric Oncology Patients
von: Brittni Kam, et al.
Veröffentlicht: (2025)

Concurrent Juvenile Myelomonocytic Leukemia and Gliomas in Patients With Neurofibromatosis Type 1
von: Henry Hongo, et al.
Veröffentlicht: (2025)

Unraveling Juvenile Hyaline Fibromatosis: A Case of Novel ANTXR2 Mutations Associated with Subcutaneous Masses and Hydronephrosis
von: Shu‐Di Zhang, et al.
Veröffentlicht: (2024)